Table 5.

Multivariable Analyses of Overall Survival Following Gastric Cancer Diagnosis by Race/Ethnicity and Birthplace

	Unadjusted HR (95% CI)	Adjusted* HR (95% CI)	Treatment Adjusted† HR (95% CI)
Non-Hispanic	1.00	1.00	1.00
White
All API	0.70 (0.68–0.73)	0.80 (0.76–0.83)	0.84 (0.80–0.87)
API by birthplace
US-born	0.86 (0.81–0.90)	0.88 (0.82–0.95)	0.96 (0.89–1.04)
Foreign-born	0.70 (0.66–0.73)	0.83 (0.79–0.87)	0.86 (0.82–0.90)
Unknown	0.52 (0.48–0.56)	0.64 (0.59–0.70)	0.67 (0.62–0.73)

^*Adjusted Hazard Ratios (aHR) < 1.00 indicate longer survival time among API patients compared to non-Hispanic White patients. Using proportional hazard regression, aHRs are adjusted for year of diagnosis, age, marital status, sex, SEER registry, stage at diagnosis, tumor location, grade, and histology.

^†Further adjusted for treatment (receipt of adequate lymph node examination, radiation therapy, and surgery).